期刊文献+

One-step RT-PCR-RFLP方法筛查新型甲型H1N1流感病毒Oseltamivir耐药株 被引量:2

Screening Oseltamivir resistant strains in pandemic influenza A( H1N1) virus by a One-step RT-PCR / restriction fragment lengthpolymorphism assay
原文传递
导出
摘要 目的分析2013年江西省甲型H1N1流感病毒神经氨酸酶(NA)基因第275位氨基酸变异情况,掌握甲型H1N1流感病毒耐药特性,为甲型H1N1流感临床治疗和疾病控制提供参考。方法收集江西省流感监测哨点医院采集的流感样病例的鼻咽拭子标本,采用狗肾传代细胞(MDCK)对标本进行病毒分离,对分离的31株新型甲型H1N1流感病毒进行核酸提取,采用一步法逆转录-聚合酶链反应(One-step RT-PCR)扩增病毒NA基因部分片段,采用限制性内切酶片段长度多态性分析(RFLP)方法,分析扩增的部分NA基因第275位是否发生组氨酸(H)到酪氨酸(Y)的突变。结果2013年江西省31株甲型H1N1流感病毒NA基因第275位氨基酸均为组氨酸,未发生变异。结论 2013年31株毒株均对Oseltamivir敏感,One-step RT-PCR-RFLP方法筛查新型甲型H1N1流感病毒Oseltamivir耐药株简便可行。 Objective To analyze the characteristics of site 275 in NA protein of pandemic influenza H1N1 virus in Jiangxi province in 2013. Methods The specimens of nasopharyngeal swabs were collected from influenza like cases of influenza monitor hospitals and isolated for influenza virus with MDCK. All 31 strains of pandemic influenza A( H1N1) 2009 virus were selected for detection and virus RNA were extracted. The specific gene fragment of NA genes were amplified by one-step RT-PCR and then were analyzed by restriction fragment length polymorphism( RFLP) assay. Results All strains of pandemic H1N1 influenza virus had no mutation in position 275 of NA gene. Conclusion 31 strains were sensitive to Oseltamivir. The One-step RT-PCR-RFLP assay is simple and feasible for screening oseltamivir resistant pandemic influenza A( H1N1)2009 virus.
出处 《中国卫生检验杂志》 北大核心 2014年第23期3409-3411,共3页 Chinese Journal of Health Laboratory Technology
  • 相关文献

参考文献8

  • 1World Health Organization. Weekly Virological Update on 05 Au- gust 2010[R]. Geneva: WHO, 2010: 29.
  • 2Nukiwa N, Suzuki A, Furuse Y, et al. Simplified screening meth- od for detecting oseltamivir resistant pandemic influenza A ( H1N1 ) 2009 virus by a RT - PCR/restriction fragment length polymorphism assay[J]. J Virol Methods, 2010, 170(1/2) : 165 -168.
  • 3熊英,龚甜,周珺,施勇,李健雄,张艳妮,徐刚,刘师文,肖芳,刘晓庆.江西省2009-2011年新型甲型H1N1流感病毒耐药性分析[J].现代预防医学,2014,41(9):1681-1685. 被引量:10
  • 4熊英,龚甜,王飞霞,施勇,周珺.江西省呼吸道合胞病毒G蛋白基因特征分析[J].中国卫生检验杂志,2014,24(12):1760-1762. 被引量:3
  • 5World Health Organization. Review of the 2013 - 2014 winter influ- enza season, northern hemisphere[ R]. Geneva: WHO, 2014 : 245 - 256.
  • 6Deyde VM, Sheu TG, Trujillo AA, et al. Detection of molecular markers of drug resistance in 2009 pandemic influenza A (HIN1) viruses by pyrosequencing [ J ]. Antimicreb Agents Chemother, 2009, 54(3) : 1102 - 1110.
  • 7Atria R, Corcioli F, Simi L, et al. Monitoring the susceptibility to oseltamivir of Influenza Influenza A( H1N1 ) 2009 virus by nested - PCR and pyrosequencing during the pandemic and in the season 2010 -2011 [J]. J Virol Methods, 2012, 184(1/2) : 113 - 116.
  • 8Van DVE, Jonges M, Herfst S, et al. Evaluation of a rapid molec- ular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key osehamivir resistance (H275Y) sub- stitution in neuraminidase [ J ]. J Clin Virol, 2010, 47 ( 1 ) : 34 - 37.

二级参考文献23

  • 1茅海燕,卢亦愚,严菊英.浙江地区呼吸道合胞病毒G基因分子特征分析[J].中国病毒学,2006,21(2):111-115. 被引量:3
  • 2蓝雨,李梓,董丽波,张烨,温乐英,张彦明,王敏,郭元吉,舒跃龙.中国H3N2亚型流感病毒烷胺类药物耐药性研究[J].中华实验和临床病毒学杂志,2006,20(2):21-23. 被引量:25
  • 3World Health Organization.WHO information for molecular diagnosis of influenza virus in humans-update [EB/OL].http://www.who.int/influenza/resources/documents/molecular_diagnosis_influenza_virus_humans_update 201108.pdP.ua= 1.
  • 4Hay AJ,Zambon MC,Wolstenhohne AJ,et al.Molecular basis of resistance of influenza A viruses to amantadine [J].J Antimicrob Chemother,1986,18(SupplB):19-29.
  • 5Cochran KW,Maassab HF,Tsunoda A,et al.Studies on the an-tiviral activity of amantadine hydrochloride [J ].Ann N Y Aead Sci,1965,130(1):432-43.
  • 6Hayden FG.Prevention and treatment of influenza in immunoeompro-mised patients [J].J Med,1997,102(3A):55-60;discussion 75-6.
  • 7Gubareva LV,Matrosovich MN,Brenner MK,et al.Evidence for zanamivir resistance in an immunocompremised child infected with influenzaB virus[J].Infect Dis,1998,178(5):1257-1262.
  • 8Wang C,Takeuchi K,Pinto LH,et al.Ion channel activity of in-fluenza A virus M2 protein:characterization of the amantadine block [J].J Virol,1993,67(9):5585-5594.
  • 9Colman PM,Varghese JN,Laver WG.Structure of the catalytic and antigenic sites in influenza virus neuraminidase [J].Nature,1983,303(5912):41-44.
  • 10Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults [J]. Clin Microbiol, 2000,13(3): 371 -384.

共引文献11

同被引文献15

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部